Outcome of treatment with concurrent whole brain radiotherapy and Temozolomide in brain metastasis

Authors

  • Md Yousuf Ali Classified Specialist in Radiotherapy, Dept of Radiation Oncology, CMH, Dhaka
  • Md Aminul Islam Classified Specialist in Surgery, CMH, Dhaka
  • SM Rokonuzzaman Classified Specialist in Radiation Oncology,, Dept of Radiation Oncology, CMH, Dhaka
  • Md Habibur Rahman Prof and Adviser Spl in Surgery, AFMC, Dhaka
  • Rukun Uddin Chowdhuyry Classified Specialist in Surgery, CMH, Dhaka
  • Arif Al Hasan OJT (Radiation Oncology), AFMI, Dhaka

DOI:

https://doi.org/10.3329/jafmc.v10i1.22927

Keywords:

Concurrent, whole brain radiotherapy, temozolomide, brain metastasis

Abstract

Introduction: Brain metastasis represents the most common form of intracranial tumor and causes significant morbidity and mortality in cancer patients. This prospective study was carried out at Radiation Oncology Department, Combined Military Hospital Dhaka from January 2010 to December 2012. The concurrent chemotherapy and radiotherapy have shown better outcome and improved the quality of life.

Objectives: To evaluate the efficacy and toxicity of concurrent treatment with whole brain radiotherapy (WBRT) and temozolomide (TMZ) in patients with brain metastasis.

Methods: Sixty patients with multiple brain metastases were enrolled and received WBRT with 30 Gray (Gy) in ten fractions with concurrent TMZ (75mg/m2/day) for ten days.

Results: Remarkable symptomatic relief occurred in eighteen (72%) patients of headache, nine (60%) patients of altered mental status, thirteen (76.5%) of vomiting, ten (71.4%) of seizure, eleven (68.7%) of altered sensation, seven (58.3%) of focal weakness and two (40%) of visual change. In relation to objective response four (6.7%) patients had complete response, twenty three (38.3%) patients had partial response while twenty one (35%) had stable disease and twelve (20%) had progressive disease. The overall response rate was 45%. The most frequent toxicities included anorexia in twenty one (35%), nausea in eighteen (30%), vomiting in ten (16.6%), lethargy in seventeen (28%), anemia in eight (13.3%) and neutropenia in thirteen (21.6%) cases. 64 JAFMC Bangladesh. Vol 10, No 1 (June) 2014

Conclusion: The concurrent treatment with whole brain radiotherapy (WBRT) and temozolomide (TMZ) in patients with brain metastasis is well tolerated with an encouraging response.

DOI: http://dx.doi.org/10.3329/jafmc.v10i1.22927

Journal of Armed Forces Medical College Bangladesh Vol.10(1) 2014

Downloads

Download data is not yet available.
Abstract
761
PDF
461

Author Biography

Md Yousuf Ali, Classified Specialist in Radiotherapy, Dept of Radiation Oncology, CMH, Dhaka



Downloads

Published

2015-04-07

How to Cite

Ali, M. Y., Islam, M. A., Rokonuzzaman, S., Rahman, M. H., Chowdhuyry, R. U., & Hasan, A. A. (2015). Outcome of treatment with concurrent whole brain radiotherapy and Temozolomide in brain metastasis. Journal of Armed Forces Medical College, Bangladesh, 10(1), 64–68. https://doi.org/10.3329/jafmc.v10i1.22927

Issue

Section

Original Papers